Page 396 - Feline Cardiology
P. 396

416  Section O: Anesthesia in the Patient with Cardiac Disease


              tachycardia.  Glycopyrrolate  is  preferred  to  atropine   alveolar concentration of sevoflurane is approximately
              because it tends to increase the heart rate less and may   1%  higher  than  that  of  isoflurane,  so  higher  require-
              cause fewer arrhythmias (Mirakhur et al. 1978). The use   ments for sevoflurane should be expected.
              of  the  alpha-2  adrenergic  agonist  medetomidine  has   Balanced  anesthetic  techniques,  most  commonly
              been  shown  to  reduce  left  ventricular  outflow  tract   based  on  utilizing  an  opioid  infusion  (fentanyl)  to
              obstruction  in  cats  with  left  ventricular  hypertrophy   reduce the amount of inhalant anesthetic and improve
              (Lamont et al. 2002); however, the effect has not been   hemodynamics,  have  often  been  advocated  in  these
              studied in anesthetized cats, and it is unclear whether   patients. However, opioids decrease inhalant anesthetic
              the  hemodynamic  effects  of  alpha-2  agonists  would   requirements only moderately (Ferreira et al. 2009; Ilkiw
              prove beneficial during anesthesia in cats with hypertro-  et  al.  1997,  2002)  or  not  at  all  in  cats  (Brosnan  et  al.
              phic cardiomyopathy. Decreased heart rate and increased   2009).  Additionally,  at  the  doses  reported  to  achieve
              systemic  vascular  resistance  (as  produced  by  alpha-2   reduced inhalant requirements, significant sympathetic
              agonists) are usually beneficial, as is the sympatholytic   stimulation has been reported (Pascoe et al. 1997), which
              effect; however, alpha-2 agonist administration does not   would be detrimental to cats with most types of heart
              provide  good  control  of  the  intensity  of  these  effects.   disease,  notably  hypertrophic  cardiomyopathy.  Low
              Moreover, alpha-2 agonists may increase arterial blood   doses of opioids could be used, but benefits other than
              pressure  beyond  desirable  values,  and  hypertension   analgesia  remain  to  be  demonstrated.  Epidural  mor-
              increases  myocardial  oxygen  consumption,  which  is   phine can be used for providing analgesia, but conflict-
              undesirable with ventricular hypertrophy. In summary,   ing results on its effect on anesthetic requirements have
              available information is insufficient to support the use   been  published  (Golder  et  al.  1998;  Pypendop  et  al.
              of  alpha-2  agonists  routinely  for  premedication  in  all   2006).  Alternatives  to  opioids  for  balanced  anesthesia
              cats with HCM. If necessary, reduction in heart rate can   that have been studied in cats include ketamine, nitrous
              be achieved by titration of a short-acting beta blocker,   oxide,  and  lidocaine.  Ketamine  and  nitrous  oxide
              such as esmolol, and increase in systemic vascular resis-  produce sympathetic stimulation and may therefore not
              tance by titration of a short-acting alpha-1 agonist such   be good choices for cats with hypertrophic cardiomy-
              as  phenylephrine.  Acepromazine  should  be  avoided   opathy  (Bovill  2006;  Ebert  and  Kampine  1989);  lido-
              because of its vasodilatory effect, and dissociative anes-  caine produces significant cardiovascular depression in
              thetics (e.g., ketamine) are contraindicated because of   normal cats (Pypendop and Ilkiw 2005a) and is not an
              the sympathetic stimulation they commonly produce.  appropriate adjunct for balanced anesthesia in the cat.
                 Induction of anesthesia is best performed by careful   Alpha-2  adrenergic  agonists  (medetomidine,  dexme-
              titration of an injectable agent to effect, because induc-  detomidine) at low doses may prove useful for balanced
              tion with inhalation agents causes excitement and release   anesthesia in cats with hypertrophic cardiomyopathy. As
              of catecholamines. Etomidate (1–2 mg/kg IV) and a ben-  in other species, in normal cats, dexmedetomidine dose-
              zodiazepine  (midazolam  0.25 mg/kg  IV  or  diazepam   dependently decreases heart rate and inhalant require-
              0.5 mg/kg IV) are preferred, particularly for severe cases   ments  and  increases  systemic  vascular  resistance
              or those with systolic dysfunction. However, this com-  (Pypendop, unpublished data), which may be beneficial
              bination is not widely used or familiar in many clinical   in  cats  with  hypertrophic  cardiomyopathy.  In  normal
              settings. For mild to moderate cases, propofol (4–8 mg/  cats anesthetized with isoflurane and without any addi-
                                                                 tional drug, optimal dosing of dexmedetomidine appears
              kg), either alone or, preferably, in combination with a
      Anesthesia  benzodiazepine,  is  an  acceptable  induction  combina-  to be a loading dose of 0.5–1 µg/kg and a constant infu-
                                                                 sion rate of 0.5–1 µg/kg/h. Local or regional anesthesia
              tion. It does cause systemic vasodilation and decreased
              afterload. Thiopental and dissociative agents (ketamine,
                                                                 decrease  anesthetic  requirements,  improve  analgesia,
              tiletamine) should be avoided, the former because of the   should be used whenever possible, since it is expected to
              tachycardia and ventricular arrhythmias it may induce,   and be safe if properly performed. For further informa-
              and  the  latter  because  of  the  sympathetic  stimulation   tion on such techniques, the reader is referred to review
              produced. Anesthesia is maintained with isoflurane or   articles and veterinary anesthesia textbooks (Duke 2000;
              sevoflurane in oxygen. Sevoflurane may be slightly pref-  Lemke and Dawson 2000; Tranquilli et al. 2007).
              erable, since data suggest that it reduces systemic vascu-
              lar resistance to a lesser extent than isoflurane and that   Systolic Myocardial Failure and
              its vasodilatory effect may reach a ceiling at low to mod-  Volume Overload
              erate concentrations (Pypendop and Ilkiw 2004). Both   Myocardial  failure  is  caused  by  decreased  myocardial
              agents should be carefully titrated to effect, according to   contractility,  and  may  be  a  primary  cardiomyopathy
              close  monitoring  of  anesthetic  depth.  The  minimum   (i.e., dilated cardiomyopathy) or more commonly sec-
   391   392   393   394   395   396   397   398   399   400   401